A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and Europe ...
People with generalized anxiety disorder improved significantly after they got a single dose of LSD powerful enough to induce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback